BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 24830318)

  • 21. Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols.
    Quigley EMM
    Curr Opin Clin Nutr Metab Care; 2022 Jul; 25(4):260-264. PubMed ID: 35762162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary treatment of irritable bowel syndrome.
    Ahmad OF; Akbar A
    Br Med Bull; 2015 Mar; 113(1):83-90. PubMed ID: 25601299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research.
    Mitchell H; Porter J; Gibson PR; Barrett J; Garg M
    Aliment Pharmacol Ther; 2019 Jan; 49(2):124-139. PubMed ID: 30589971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Irritable Bowel Syndrome: Physician-Dietitian Collaboration.
    Ireton-Jones C; Weisberg MF
    Nutr Clin Pract; 2020 Oct; 35(5):826-834. PubMed ID: 32786046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.
    Weynants A; Goossens L; Genetello M; De Looze D; Van Winckel M
    J Hum Nutr Diet; 2020 Apr; 33(2):159-169. PubMed ID: 31637777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge.
    Pensabene L; Salvatore S; Turco R; Tarsitano F; Concolino D; Baldassarre ME; Borrelli O; Thapar N; Vandenplas Y; Staiano A; Saps M
    J Pediatr (Rio J); 2019; 95(6):642-656. PubMed ID: 31028745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restriction of FODMAP in the management of bloating in irritable bowel syndrome.
    Wong WM
    Singapore Med J; 2016 Sep; 57(9):476-84. PubMed ID: 27664186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].
    Ingvarsdottir IE; Engilbertsdottir S; Halldorsson TI; Bjornsson ES; Gunnarsdottir I
    Laeknabladid; 2024 Jun; 110(6):298-306. PubMed ID: 38809220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
    Wilson B; Whelan K
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():64-68. PubMed ID: 28244671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of FODMAPs in Patients With Irritable Bowel Syndrome.
    Mansueto P; Seidita A; D'Alcamo A; Carroccio A
    Nutr Clin Pract; 2015 Oct; 30(5):665-82. PubMed ID: 25694210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in the treatment of irritable bowel syndrome: indications and design.
    Zugasti Murillo A; Estremera Arévalo F; Petrina Jáuregui E
    Endocrinol Nutr; 2016 Mar; 63(3):132-8. PubMed ID: 26830853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adapting the low FODMAP diet to special populations: infants and children.
    Iacovou M
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():43-45. PubMed ID: 28244674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.
    Van den Houte K; Colomier E; Routhiaux K; Mariën Z; Schol J; Van den Bergh J; Vanderstappen J; Pauwels N; Joos A; Arts J; Caenepeel P; De Clerck F; Matthys C; Meulemans A; Jones M; Vanuytsel T; Carbone F; Tack J
    Gastroenterology; 2024 Jul; 167(2):333-342. PubMed ID: 38401741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term personalized low FODMAP diet in IBS.
    De Palma G; Bercik P
    Neurogastroenterol Motil; 2022 Apr; 34(4):e14356. PubMed ID: 35293089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():32-35. PubMed ID: 28244668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FODMAPs: food composition, defining cutoff values and international application.
    Varney J; Barrett J; Scarlata K; Catsos P; Gibson PR; Muir JG
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():53-61. PubMed ID: 28244665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis.
    Altobelli E; Del Negro V; Angeletti PM; Latella G
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28846594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.